Literature DB >> 6472031

Patient's evaluation of argon laser therapy of port wine stain, decorative tattoo, and essential telangiectasia.

J A Dixon, R H Rotering, S E Huether.   

Abstract

One hundred fourteen patients were studied to assess their perception of the results of argon laser therapy for port wine stains (PWS), tattoos, or essential telangiectasia of legs. At least 1 yr following treatment patients were surveyed using a 30-item mail questionnaire. A 91% response rate was achieved. The findings indicate that patients with PWS and tattoo treated with argon laser are moderately satisfied with the results and 85% of them would have treatment again. Laser therapy of these lesions should be continued. Treatment results of essential telangiectasia of the legs are disappointing and only 49% of patients would have treatment again. Discontinuance of argon laser therapy using the described techniques is recommended.

Entities:  

Mesh:

Year:  1984        PMID: 6472031     DOI: 10.1002/lsm.1900040210

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  4 in total

1.  Copper vapor and dye laser therapy for cutaneous vascular disorders.

Authors:  R G Wheeland
Journal:  West J Med       Date:  1989-12

2.  Evaluation of the Efficacy and Safety Profile of Long-Pulsed 1064 Neodymium:Yttrium-Aluminum-Garnet (Nd:YAG) Laser in Hemangioma and Vascular Malformation in Darker Skin Types.

Authors:  Manmit Kaur Hora; Nishant Choudhary; Surbhi Agrawal; Shreya Gupta; Jagriti Gandhi; Abhishek De; Gobinda Chatterjee
Journal:  Cureus       Date:  2022-06-08

3.  Cutaneous laser therapy.

Authors:  J A Dixon; J J Gilbertson
Journal:  West J Med       Date:  1985-12

4.  Treatment of hemangiomas in children using a Nd:YAG laser in conjunction with ice cooling of the epidermis: techniques and results.

Authors:  Ioannis Vlachakis; Stefanos Gardikis; Eleni Michailoudi; Georgios Charissis
Journal:  BMC Pediatr       Date:  2003-04-12       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.